Calendrier des promotions AstraZeneca PLC
Calendrier avancé
Graphique simple
À propos de l'entreprise AstraZeneca PLC
AstraZeneca PLC обнаруживает, разрабатывает, производит и продает рецептурные лекарства в области онкологии, сердечно-сосудистой системы, почек и обмена веществ, респираторных заболеваний, инфекций, нейробиологии и гастроэнтерологии по всему миру. plus de détailsParamètres de base
ISIN
GB0009895292
Industry
Pharmaceuticals
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
2.07
Дивиденд ао
3.11
Сайт
Grade
Sous-estimation
| Nom | Signification | Grade |
| P/S | 3.76 | 4 |
| P/BV | 4.98 | 3 |
| P/E | 28.91 | 6 |
Efficacité
| Nom | Signification | Grade |
| ROA | 6.86 | 2 |
| ROE | 17.6 | 5 |
| ROIC | -0.09 | 0 |
Dividendes
| Nom | Signification | Grade |
| Rendement en dividendes | 1.93 | 4.83 |
| DSI | 0.7857 | 7.86 |
| Croissance moyenne du dividende | 2.14 | 3.57 |
Devoir
| Nom | Signification | Grade |
| Debt/EBITDA | 1.76 | 7 |
| Debt/Ratio | 0.2895 | 10 |
| Debt/Equity | 1.55 | 7 |
Impulsion de croissance
| Nom | Signification | Grade |
| Rentabilité Revenue, % | 103.15 | 10 |
| Rentabilité Ebitda, % | 105.36 | 10 |
| Rentabilité EPS, % | 84.58 | 9 |
Dividendes
paper.price.prices
| Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
| common.calendar.number_days.1 | 150.11 $ | 0 $ | 0 $ | -0 % | 0 % | 0 % |
| common.calendar.number_days.7d | 144.32 $ | 0 $ | 0 $ | 4 % | 0 % | 0 % |
| common.calendar.number_days.30d | 141.12 $ | 141.5 $ | 150.1 $ | 6.36 % | 0 % | 0 % |
| common.calendar.number_days.90d | 129.16 $ | 128.91 $ | 150.84 $ | 16.21 % | 0 % | 0 % |
| common.calendar.number_days.180d | 139.54 $ | 128.91 $ | 157.58 $ | 7.57 % | 0 % | 0 % |
| common.calendar.number_days.1y | 171 $ | 124.7 $ | 175 $ | -12.22 % | 0 % | 0 % |
| common.calendar.number_days.3y | 126.59 $ | 104.5 $ | 175 $ | 18.57 % | 0 % | 0 % |
| common.calendar.number_days.5y | 110.05 $ | 94.71 $ | 175 $ | 36.39 % | 0 % | 0 % |
| common.calendar.number_days.10y | 0 $ | 49.89 $ | 175 $ | 0 % | 0 % | 0 % |
| common.calendar.number_days.ytd | 142.85 $ | 128.91 $ | 157.58 $ | 5.08 % | 0 % | 0 % |
Principaux propriétaires
Contenu dans l'ETF
ETF | Partager, % | Rentabilité pour l'année, % | Commission, % |
FinEx Ex-USA ETF USD
|
1.6 | 45.15 | 0.9 |
| 1,6 | 45,15 | 0,9 |
|---|
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
| Mr. Pascal Soriot D.V.M., M.B.A. | CEO & Executive Director | 5.76M | 1959 (66 années) |
| Dr. Aradhana Sarin M.D. | CFO & Executive Director | 3.18M | 1974 (51 année) |
| Ms. Pam P. Cheng | EVP of Global opt. & IT, Chief Sust. Officer and Member of External Sust.Adv. Board | N/A | 1970 (55 années) |
| Mr. Jeffrey Pott | CHRO, Chief Compliance Officer, General Counsel & Member of External Sustainability Advisory Board | N/A | |
| Gonzalo Vina | Head of Global Media Relations | N/A | |
| Dr. Ruud Dobber Ph.D. | Executive Vice-President of BioPharmaceuticals Business Unit | N/A | |
| Mr. Andrew P. Barnett | Head of Investor Relations | N/A | |
| Dr. Susan Mary Galbraith M.D., Ph.D. | Executive Vice President of Oncology Research & Development | N/A | 1966 (59 années) |
| Mr. Leon Wang | Executive VP of International & China President | N/A | |
| Ms. Iskra Reic | Executive Vice-President of Vaccines & Immune Therapies |
Informations sur l'entreprise
Adresse: United Kingdom, Cambridge CB AA, 1 Francis Crick Avenue - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.astrazeneca.com
Site web: https://www.astrazeneca.com
